-
Mashup Score: 1
Use of biologics to treat moderate to severe systemic lupus erythematosus increased 45% between 2021 and 2023, according to recent findings from a market analysis conducted by Spherix Global Insights.The analysis additionally found that nearly half of moderate-to-severe patients with SLE are currently on a biologic. Meanwhile, among those not currently on a biologic, 73% are considered a
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0‘On the cusp’ of something big: New insights into the microbiome’s role in immunity - 5 month(s) ago
As of just a few years ago, early enthusiasm over the apparent interplay between the gut microbiome and the immune system, and that it was driving or exacerbating certain rheumatic diseases, seemed to have all but dried up.The data at the time had failed to move the bar beyond correlation, and the potential for any sort of clinical utility or therapy seemed scant.
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2First Rheumatology Private Practice Alliance summit to ‘help your private practice rise’ - 6 month(s) ago
Approximately 125 rheumatologists and fellows are set to participate in the first Rheumatology Private Practice Alliance Growth Summit, where attendees will discuss the complicated world of private practice management in the specialty. Scheduled for Friday, Oct. 27, through Sunday, Oct. 29, at the Hyatt LAX in Los Angeles, the inaugural summit will feature talks on retaining physicians and
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 1Targeting IL-6 can help rheumatologists, patients ‘seek shelter from the cytokine storm’ - 9 month(s) ago
Targeting interleukin-6 can help rheumatologists manage severe, high-grade inflammation including cytokine storm, according to a presenter at the 2022 AWIR annual conference.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Changes in Service Delivery and Access to Rheumatologists Before and During the COVID-19 Pandemic in a Canadian Universal Healthcare Setting - 10 month(s) ago
Objective To describe changes in service delivery and access to rheumatologists before and during the coronavirus disease 2019 (COVID-19) pandemic periods. Methods We conducted a population-based study in Ontario, Canada. Patient visits with rheumatologists were ascertained using billing claims data. Contact with rheumatologists was defined separately by the type of patient encounter (including…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1POS1182 GENDER IMPACT ON BASELINE PRESENTATION AND OUTCOME IN ADULT IGA VASCULITIS - 11 month(s) ago
Background It has been shown that patient’s demographical characteristics may impact presentation and outcome in adult IgA vasculitis (IgAV). Aging was shown to negatively impact disease severity and outcome of adult IgAV. IgAV is also known to be more frequent in male, with a male to female gender ratio of 1.6. However, the potential impact of gender during vasculitis has been…
Source: Annals of the Rheumatic DiseasesCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1
Generally positive perception of vaccines; chatrooms and social media fuel skepticism
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Data from the UPLIFT study show patients with psoriatic arthritis and their physicians see eye-to-eye on most subjects—except for treatment goals.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Here's Another Way the Pandemic Punished Rheumatologists - 1 year(s) ago
Industry payments crashed, have yet to recover
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Most gastroenterologists reported higher familiarity with adalimumab biosimilars and reported greater comfort levels in prescribing biosimilars than dermatologists or rheumatologists, according to a recent survey. In its 2023 Biosimilars Report, Cardinal Health surveyed 350 providers in rheumatology, gastroenterology, dermatology and ophthalmology to assess market trends and changing perspectives
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
‘Exciting time’ for biologic use in lupus. #rheumatologists weigh in on prescribing habits in recent survey. 🩺🙋♀️🙋♂️ Catch the excitement on @HealioRheum ➡️ https://t.co/nv92HfJxcD